Skip to main content
. 2013 Sep 24;122(23):3735–3740. doi: 10.1182/blood-2013-06-498303

Table 3.

VWD therapeutic management

VWD treatment considerations
Is desmopressin likely to be effective? • Baseline VWF level >10%
• Conduct desmopressin trial (IV, SC, IN)
• Test VWF:Ag, VWF:RCo, and FVIII:C levels at 1, 2, and 4 hours
• Positive response both FVIII and VWF > 50% after administration
Addition of adjunctive therapies • Antifibrinolytics
• For menorrhagia: oral contraceptive or levonorgestrel-releasing IUD
VWF concentrates • If desmopressin response is inadequate
• If desmopressin is required for several consecutive days
• Dosing/product considerations
 VWF/FVIII ratio
 VWF multimer profile
 Dosing by VWF:RCo or FVIII:C
 Potential for prophylactic schedule
 Rare development of VWF alloantibodies